Your browser doesn't support javascript.
loading
First Report of Management of Sequential Small Cell Transformation and ALK I1171T Mutation as Resistance Mechanisms in a Patient With ALK-EML4 Fused Non-Small Cell Lung Adenocarcinoma With a Novel Combination of Temozolomide and Lorlatinib: A Case Report.
Majeed, Umair; Li, Shenduo; Seegobin, Karan; Nassar, Aziza; Manochakian, Rami; Zhao, Yujie; Lou, Yanyan.
Affiliation
  • Majeed U; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida.
  • Li S; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida.
  • Seegobin K; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida.
  • Nassar A; Division of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida.
  • Manochakian R; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida.
  • Zhao Y; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida.
  • Lou Y; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida.
JTO Clin Res Rep ; 4(7): 100536, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37456921
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JTO Clin Res Rep Year: 2023 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JTO Clin Res Rep Year: 2023 Document type: Article Country of publication: Estados Unidos